Etelcalcetide Intravenous and Insulin Degludec (U-100) Vials
Determining the interaction of Etelcalcetide Intravenous and Insulin Degludec (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: etelcalcetide
Brand name: Parsabiv
Synonyms: Etelcalcetide
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Etelcalcetide Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Etelcalcetide Intravenous-Insulin degludec and liraglutide
- Etelcalcetide Intravenous-Insulin degludec and liraglutide Subcutaneous
- Etelcalcetide Intravenous-Insulin degludec Subcutaneous
- Etelcalcetide Intravenous-Insulin detemir
- Etelcalcetide Intravenous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Insulin Degludec (U-100) Vials-Eth-Oxydose
- Insulin Degludec (U-100) Vials-Ethacrynate Sodium
- Insulin Degludec (U-100) Vials-Ethacrynate Sodium Injection
- Insulin Degludec (U-100) Vials-Ethacrynate sodium Intravenous
- Insulin Degludec (U-100) Vials-Ethacrynic acid
- Insulin Degludec (U-100) Vials-Ethacrynic Acid Injection